From Prescription to Refill, Access Support Is Available for Every Step of LIVMARLI Treatment
Getting Patients Started
Mirum Access Plus (MAP) Support Program
If you'd like to prescribe LIVMARLI for your patient, download the Patient Enrollment Form. Once you have filled out the form and/or have your patient consent for MAP services, fax it to MAP at 1-855-282-4884.Download the Patient Enrollment Form
You can also digitally prescribe LIVMARLI through your electronic medical records by submitting an eRX straight to Eversana Life Science Services, our single-source specialty pharmacy.
Refer to this step-by-step guide for more information on prescribing LIVMARLI.
MAP is available to help you, your office, and your patient not only get started with LIVMARLI after you’ve prescribed it, but also to provide support throughout treatment. For new patients, you can begin treatment discussions by providing the Patient Brochure (English | Español) for an overview of LIVMARLI.
Read on to learn about the details of MAP support or see the resources available to you and your patients.
If you have any questions about MAP, contact us at
Monday through Friday, 8:00 AM through 8:00 PM ET.
Ready, Set, Go
Getting Your Patients the Treatment They Need
Support and resources are available through MAP to help you and your office navigate insurance coverage, as well as assist your patients in treatment costs and prescription fulfillment.
Insurance Coverage and Access Support
Throughout the payer approval process, MAP works closely with you, your patients, and the insurance plan to help ensure patients get the treatment they need. Consider the following resources to help your patients access LIVMARLI:
Financial Support for Patients
MAP provides financial support options:
MAP Savings Program: Eligible patients with commercial or private insurance* may pay as little as $10 out of pocket per fill for LIVMARLI.†
Mirum Patient Assistance Program (PAP): Provides LIVMARLI at no cost for up to 1 calendar year for patients without insurance coverage, with eligibility reviewed each year.†
as little as $10 out of
pocket per fill for LIVMARLI†
Single-Source Specialty Pharmacy
MAP is a single-source specialty pharmacy that will ship LIVMARLI directly to patients, provide 24/7 access to pharmacists, and proactively manage refills.
*Exceptions apply for some patients, including those with TRICARE insurance.
*Subject to program terms and conditions.
By Your Side at Every Turn
A Team Dedicated to Alagille Syndrome
Focus on what matters and leave the rest to our experienced and dedicated team at MAP, who will work with your office staff through the access process and assist your patients at every turn.
Available to your office staff and your patients, MAP Coordinators are experts who specialize in the insurance coverage process and available financial support options.
Navigators will connect with your patients to provide health education and the emotional support needed to address the difficulties of living with Alagille syndrome.
Your Patients Can Easily Enroll in MAP
Speak with your patients about enrolling in the MAP support program through one of the following options.
If your patients choose to enroll in the free enhanced MAP program, they will have access to an even wider range of support services tailored to them:
Navigators can support all patients by answering questions about LIVMARLI, the disease, or access process. For patients who have provided their consent, navigators can help track treatment goals, develop a support network, and prepare for health care appointments.
Navigators can help reinforce adherence in consenting patients by introducing and discussing tools to track pruritus. They will also encourage communication between patients and their physicians about pruritus levels and xanthomas.
MAP Mobile allows your patients to interact with the program through their mobile devices. Patients can easily provide insurance information, eSign documents to speed up processing, follow the steps to getting their medication with a prescription tracker, and get reminders via text messaging.
Significant improvements in cholestatic pruritus from baseline were achieved as early as Week 3 and maintained through 1 year in patients with Alagille syndrome taking LIVMARLI (P<0.0001).1,2See the Efficacy Data
Encourage patients to download the Itch✓ app to help them track symptom patterns over time and generate customized reports to share at appointments.Check Out the Itch✓ App
LIVMARLI has a well-characterized safety and tolerability profile for cholestatic pruritus in patients with Alagille syndrome who are ≥1 year old.3,4See the Safety Profile